(Reuters) -German healthcare group Fresenius raised its operating profit guidance for 2025 on Wednesday, citing strong earnings growth seen in the first three quarters of the year.
The Hessian-based company expects its earnings before interest and taxes to grow by 4% to 8% on a constant currency basis, after previously guiding for a range of 3% to 7%.
This is the company’s second outlook raise this year, as it already raised its revenue expectations in August, targeting 5% to 7% organic revenue growth, instead of the formerly guided 4% to 6%.
Fresenius also posted a mixed set of third-quarter results, with a beat on operating earnings but a slight miss on revenue.
Quarterly EBIT was 574 million euros ($669 million), versus analysts’ expectations of 562 million, according to a poll by Vara Research. Revenue reached 5.48 billion euros, while analysts were expecting 5.5 billion euros on average.
($1 = 0.8575 euros)
(Reporting by Tristan Veyet in Gdansk, Patricia Weiss in Frankfurt, editing by Milla Nissi-Prussak)
